In summary, our current findings suggest that novel mutations in the MKRN3 proximal promoter and especially in the 5′-UTR region resulted in MKRN3 deficiency therefore contributing to the clinical manifestation of CPP phenotype. The gene discussed is MKRN3; the disease is central precocious puberty.